Gonadotropin-releasing hormone agonist

治療方式會隨病因而不同。選項可能包括激素生育控制（英语：hormonal birth control）、性腺激素釋放素促進劑（英语：gonadotropin-releasing hormone agonist）、傳明酸、非甾体抗炎药，或是像子宫内膜去除術（英语：endometrial

Endocrine treatment of male-to-female transsexuals using gonadotropin-releasing hormone agonist. Experimental and Clinical Endocrinology & Diabetes. December

Madelon. Cochrane Gynaecology and Fertility Group , 编. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted

和腦下垂體中風（英语：Pituitary apoplexy）。怀孕期使用可能会伤害婴儿。它属于促性腺素釋素調節劑（英语：Gonadotropin-releasing hormone modulator）家族， 可降低促性腺激素，而降低睾酮和雌二醇。 亮丙瑞林于 1973 年获得专利，于 1985 年取得美国的醫療使用許可

mineral density in male-to-female transsexuals receiving gonadotropin-releasing hormone agonist in the absence of testosterone. European Journal of Endocrinology